Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
StrR-like Regulators Enhance A40926 Production: New Insights
2026-05-30
This article examines a recent study demonstrating that heterologous expression of certain StrR-like regulatory genes can significantly enhance the biosynthesis of glycopeptide antibiotics, including A40926, in actinomycetes. The findings offer a new strategy for activating and boosting production of clinically relevant antibiotics and provide a framework for regulatory gene manipulation in antibiotic discovery.
-
Validating Metabolite Regulation of TET2 Dioxygenase: Protoc
2026-05-29
This article examines a 2025 protocol that integrates biochemical assays and STD NMR spectroscopy to validate metabolite binding and regulatory effects on TET2 dioxygenase. The approach enables precise identification of both activators and inhibitors, offering a robust framework for studying the interplay between cellular metabolism and epigenetic enzyme activity.
-
ILF3 Stabilizes SLC3A2 mRNA to Confer Ferroptosis Resistance
2026-05-29
This study identifies ILF3 as a key RNA-binding protein that elevates resistance to ferroptosis in colorectal cancer by stabilizing SLC3A2 mRNA, thereby promoting cystine uptake and glutathione synthesis. The findings highlight a mechanistic link between tumor inflammatory signaling, ILF3 regulation, and ferroptosis evasion, offering new therapeutic targets for overcoming drug resistance in cancer.
-
CTDNEP1-NEP1R1 Complex: Differential Roles in ER Lipid Regul
2026-05-28
This study elucidates how the CTDNEP1-NEP1R1 complex differentially regulates ER membrane synthesis and lipid storage through selective stabilization and interaction mechanisms. The findings refine our understanding of lipid homeostasis, with implications for dissecting protein and lipid quality control in mammalian cells.
-
CB-5083: Precision p97 Inhibition for Tumor Growth Suppressi
2026-05-28
CB-5083 empowers researchers to disrupt protein homeostasis and induce apoptosis in cancer models with exceptional selectivity. This article details applied workflows, advanced troubleshooting, and the latest insights bridging p97 inhibition with ER lipid regulation, setting a new benchmark for reproducible oncology research.
-
Bafilomycin A1: Unlocking V-ATPase Function in Centrosomal R
2026-05-27
Explore Bafilomycin A1 as a selective V-ATPase inhibitor for advanced centrosomal and lysosomal function research. This article uniquely bridges ion transport inhibition with proteostasis and cell cycle regulation, offering fresh insights for cell biology and cancer research.
-
NBC19: Advanced NLRP3 Inflammasome Inhibitor for Inflammatio
2026-05-27
NBC19 empowers researchers to dissect NLRP3 inflammasome signaling with nanomolar precision, offering robust IL-1β suppression under Nigericin and ATP stimulation. Its validated efficacy in THP1 models and actionable protocol guidance make it a go-to tool for translational inflammation and metastasis research.
-
Aconitase Activity Colorimetric Assay Kit: Oxidative Stress
2026-05-26
Explore how the Aconitase Activity Colorimetric Assay Kit empowers precise quantification of mitochondrial aconitase activity as a biomarker of oxidative stress, with unique insights into metabolic flexibility and T cell immunometabolism. This article offers an advanced, evidence-based analysis distinct from prior reviews.
-
MLN4924: NEDD8-Activating Enzyme Inhibitor for Cancer Resear
2026-05-26
MLN4924 empowers cancer biology researchers with precise, robust inhibition of the neddylation pathway, making it an essential tool for dissecting protein degradation mechanisms. This guide details optimized workflows, applied use-cases, and expert troubleshooting for maximizing the value of MLN4924 in advanced experimental settings.
-
Optimizing Cell-Based Assays: Practical Scenarios with PR-61
2026-05-25
This authoritative guide addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how PR-619 (SKU A8212) delivers reproducible, data-driven solutions across ubiquitination pathway research. By leveraging scenario-based Q&A, the article highlights PR-619's unique technical profile and workflow advantages for biomedical researchers.
-
Sulfo-NHS-LC-Biotin: Practical Guide for Cell Surface Biotin
2026-05-25
Sulfo-NHS-LC-Biotin enables selective, irreversible biotin labeling of cell surface or soluble proteins in aqueous solutions, providing stable targets for biotin-avidin detection, purification, or immobilization. Researchers should use this reagent for workflows requiring covalent modification of primary amines on accessible proteins, not for intracellular or reversible labeling tasks.
-
Ertugliflozin (PF-04971729): Translational Science from SGLT
2026-05-24
Explore the multifaceted scientific landscape of Ertugliflozin (PF-04971729), a highly selective SGLT2 inhibitor. This article delivers a deep dive into its translational mechanisms, cardiovascular evidence, and advanced assay implications, offering researchers a unique, evidence-driven perspective.
-
ABT-263 (Navitoclax): Enabling Precision Apoptosis Assays
2026-05-23
ABT-263 (Navitoclax) unlocks advanced, quantitative apoptosis workflows in cancer research, excelling in combination strategies and challenging resistance models. Learn how to optimize protocols, troubleshoot solubility, and leverage insights from recent high-impact studies.
-
Vitamin C (CAS 50-81-7): Paradigm Shifts in Anticancer and A
2026-05-22
Explore how high-purity Vitamin C (ascorbic acid) is transforming organoid-based cancer and antiviral research, with a focus on mechanistic insights and translational impact. This article uniquely bridges recent organoid innovations with the evolving landscape of in vitro modeling.
-
Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Precisi
2026-05-22
Sulfo-Cy3 NHS Ester empowers researchers to achieve high-efficiency, hydrophilic fluorescent labeling of challenging proteins and peptides without organic solvents. Its performance in advanced vascular remodeling studies and compatibility with aqueous workflows set it apart for applications demanding high solubility, minimal quenching, and reproducible results.